Filing Analysis
Selectis Health, Inc. has entered into a definitive merger agreement with Black Pearl Equities II, LLC to be acquired in an all-cash transaction at $5.75 per share. The deal is structured as a cash tender offer and will result in the company becoming a wholly owned subsidiary of the purchaser.
🚩 Red Flags
- Minimum tender condition (70%) introduces execution risk if enough shareholders participate.
- Appraisal rights could potentially impact the final deal structure or value if high volume is exercised.
📋 Key Facts
- Acquisition price: $5.75 per share in cash.
- Purchaser: Black Pearl Equities II, LLC (via its subsidiary Tortuga Acquisition Sub, Inc.).
- Minimum tender condition: At least 70% of outstanding shares must be validly tendered.
- Appraisal rights limit: Shares exercised under appraisal rights cannot exceed 15%.
- Cash requirement: Company must demonstrate aggregate unrestricted cash of at least $6.8 million (with $2.88 million in escrow).
- Termination fee: $400,000 payable by either party under specific circumstances.
- The Board of Directors has unanimously approved the merger and recommended that stockholders accept the offer.
Selectis Health, Inc. announced the appointment of WithumSmith+Brown, PC as its new independent registered public accounting firm, effective December 4, 2024.
🚩 Red Flags
- Sudden auditor change in a micro-cap entity can sometimes signal disagreements, though no restatement was explicitly noted in this filing.
📋 Key Facts
- Effective date of auditor change: December 4, 2024.
- New Auditor: WithumSmith+Brown, PC ('Withum').
- The appointment was approved by the Board of Directors upon recommendation from the Audit Committee.
- The company had not previously consulted with Withum regarding specific accounting principles or audit opinions prior to this engagement.
Selectis Health, Inc. has terminated its relationship with Marcum LLP as its independent auditor effective November 20, 2024. The company has not yet engaged a successor accounting firm.
🚩 Red Flags
- Auditor change (Item 4.01) without a successor in place is a significant red flag for micro-cap companies.
- Historical 'going concern' warnings were included in the 2022 and 2023 audit reports.
- The absence of a new auditor suggests potential difficulties in securing professional services or resolving underlying financial/reporting issues.
📋 Key Facts
- Marcum LLP terminated its relationship with the company on November 20, 2024.
- The company reports no disagreements with Marcum LLP regarding accounting principles or auditing scope prior to termination.
- Previous audit reports for years ended December 31, 2022, and December 31, 2023, contained explanatory paragraphs regarding the Company's ability to continue as a going concern.
- The company has not yet engaged a new independent registered public accounting firm.
Selectis Health, Inc. announced a compensation adjustment for CEO Adam Desmond effective October 1, 2024. The change involves an increase in annual base salary offset by the forfeiture of quarterly Board Compensation stipends.
🚩 Red Flags
- None identified in this specific filing.
📋 Key Facts
- CEO Adam Desmond's annual salary increased from $150,000 to $250,000.
- The new salary is payable weekly.
- Effective date: October 1, 2024.
- Mr. Desmond agreed to forgo the Company’s Board Compensation stipend of $7,500 quarterly.
Selectis Health, Inc. announced the appointment of James Creamer as Chief Financial Officer, effective August 15, 2024. Mr. Creamer transitions from his previous role as Interim CEO to the CFO position.
🚩 Red Flags
- Transition from Interim CEO to CFO suggests a potential reshuffling of leadership or stabilization efforts following previous interim management.
📋 Key Facts
- James Creamer appointed as Chief Financial Officer (CFO) effective August 15, 2024.
- Mr. Creamer previously served as the Company's Interim CEO since December 2023.
- Base salary for the CFO position is set at $180,000 per year.
- The appointment was approved by the Board of Directors on August 27, 2024.
Selectis Health, Inc. announced the resignation of Andrew Sink from its Board of Directors, effective June 30, 2024. The company stated there are currently no immediate plans to fill the resulting vacancy.
🚩 Red Flags
- Board member departure without an immediate replacement plan can sometimes indicate internal governance shifts or disagreements, though not explicitly stated here.
📋 Key Facts
- Andrew Sink resigned from the Board of Directors on June 24, 2024.
- The resignation became effective as of June 30, 2024.
- The company has no immediate plans to fill the vacancy created by the departure.
Selectis Health, Inc. has completed the sale of its Archway Transitional Care Center in Macon, Georgia, for $6.75 million. The transaction involves the transfer of real estate, buildings, and certain personal property to Bibb County Holdings II, LLC.
🚩 Red Flags
- Significant reduction in total assets from $39.56M to $36.79M.
- The company remains in an accumulated deficit position ($17.48M pro forma) despite the gain on sale.
📋 Key Facts
- Sale price: $6.75 million.
- Asset sold: Archway Transitional Care Center (Macon, Bibb County, Georgia) including real estate and improvements.
- Purchaser: Bibb County Holdings II, LLC.
- Closing date: June 18, 2024.
- Pro forma impact for Q1 2024 shows a net income increase from ($1,042,220) to $317,910 due to the gain on sale of asset ($1,639,301).
- The sale results in an increase in cash and accounts receivable but a significant reduction in property and equipment (net decrease of ~$4.2M).
Selectis Health, Inc. announced via a press release that its subsidiary, Goodwill Hunting, LLC, has entered into a definitive agreement to sell the Archway Transitional Care Center property in Macon, Georgia, for $6.75 million.
🚩 Red Flags
- Asset disposition of a skilled nursing facility may indicate a shift in business model or a need for immediate liquidity.
📋 Key Facts
- Seller: Wholly-owned subsidiary Goodwill Hunting, LLC
- Purchaser: Bibb County Holdings II, LLC
- Asset being sold: Real property located in Macon, Bibb County, Georgia (Archway Transitional Care Center)
- Transaction Value: $6.75 million (subject to customary prorations and adjustments)
- The PSA was previously filed as an exhibit on May 8, 2024.
Selectis Health, Inc. entered into a definitive Purchase and Sale Agreement (PSA) to sell its skilled nursing facility, Archway Transitional Care Center, located in Macon, Georgia. The transaction involves the sale of several tax parcels for a total purchase price of $6,750,000.
🚩 Red Flags
- The sale of a primary asset/facility may impact the company's operational capacity or revenue streams.
- Transaction is contingent upon various conditions; no guarantee of consummation.
📋 Key Facts
- Agreement date: May 1, 2024
- Seller: Goodwill Hunting, LLC (wholly-owned subsidiary of Selectis Health, Inc.)
- Purchaser: Bibb County Holdings II, LLC
- Asset being sold: Archway Transitional Care Center and associated tax parcels in Macon, GA
- Total purchase price: $6,750,000 (subject to customary prorations and adjustments)
Selectis Health, Inc. entered into a Commercial Line of Credit Agreement and Note with Southern Bank on April 12, 2024. The agreement provides for a line of credit with a principal limit of $750,000.
🚩 Red Flags
- Relatively small credit facility ($750k) may indicate limited access to larger capital markets or tight liquidity for a micro-cap entity.
- Short maturity term (one year from the date of agreement).
📋 Key Facts
- Entered into a Commercial Line of Credit Agreement and Note with Southern Bank on April 12, 2024.
- Principal amount limit: $750,000.
- Fixed interest rate: 8.50% per annum.
- Maturity Date: April 12, 2025.
Selectis Health, Inc. announced that Adam Desmond has been appointed as the permanent Chief Executive Officer, effective March 18, 2024, transitioning from his previous role as Interim CEO.
📋 Key Facts
- Adam Desmond appointed as Chief Executive Officer effective March 18, 2024.
- Desmond transitions from the position of Interim CEO to permanent CEO.
- Compensation for Mr. Desmond remains unchanged following the appointment.
Selectis Health, Inc. announced the Board of Directors' approval of a new form of Indemnity Agreement for its officers and directors, effective March 18, 2024.
📋 Key Facts
- The Board approved a form of Indemnity Agreement for officers and directors on March 18, 2024.
- The agreement was filed as Exhibit 10.1 to the current report.
- CEO Adam Desmond signed the filing on March 25, 2024.
Selectis Health, Inc. announced the termination of a previously announced sale agreement for its Georgia subsidiaries by the Purchaser. The Purchaser cited alleged events of default, which the Company categorically denies.
🚩 Red Flags
- Failure of a major asset sale (Georgia subsidiaries) that was previously disclosed as part of the company's strategy.
- Legal dispute/litigation risk arising from 'Events of Default' claims by the Purchaser.
- Potential impact on liquidity and cash flow if the sale was intended to fund operations or reduce debt.
📋 Key Facts
- Effective date of termination: February 20, 2024.
- The termination involves the Purchase and Sale Agreement (PSA) and Operations Transfer Agreement (OTA) for Georgia subsidiaries.
- The original sale was previously reported in an 8-K filed on December 5, 2023.
- The Purchaser claims 'Events of Default' occurred; Selectis Health denies these claims.
- Selectis Health intends to pursue all available legal rights and remedies.